The hepatocyte nuclear factor 3/fork head homolog (HFH) proteins are an extensive family of transcription factors which share homology in the winged helix DNA binding domain. Members of the winged helix family have been implicated in cell fate determination during pattern formation, in organogenesis and in cell type-specific gene expression. In this study, we used in situ hybridization to identify the cellular expression pattern of the winged helix transcription factor, HFH-8, during mouse embryonic development. We showed that HFH-8 expression initiates during the primitive streak stage of mouse embryogenesis in the extraembryonic mesoderm and in the lateral mesoderm which gives rise to the somatopleuric and splanchnopleuric mesoderm. During organogenesis, HFH-8 expression is found in the splanchnic mesoderm in close apposition of the gut endoderm, suggesting a role in mesenchymal-epithelial induction of lung and gut morphogenesis. HFH-8 expression continues in lateral mesoderm-derived tissue throughout mouse development. HFH-8 expression is observed in the mesenchymal cells of the oral cavity, esophagus, trachea, lung, intestine, dorsal aorta and intersomitic arteries, but not in the vasculature of the head, liver, kidney or heart. Consistent with these embryonic expression studies, adult HFH-8 expression is restricted to the endothelium and connective fibroblasts of the alveolar sac and in the lamina propria and smooth muscle of the intestine. We also show that several adult endothelial cell lines maintain abundant HFH-8 expression. Furthermore, we used our determined HFH-8 consensus sequence to identify putative target genes expressed in pulmonary and intestinal mesenchymal cells. Cotransfection assays with one of these target promoters, Pselectin, demonstrated that HFH-8 expression was required for IL-6 stimulation of P-selectin promoter activity and suggest that HFH-8 is involved in mediating its cell-specific transcriptional activation in response to cytokines.
Introduction
Cellular differentiation results in transcriptional induction of distinct sets of cell-specific genes whose expression is required for organ function. Cell-specific gene transcription involves the combinatorial interaction of multiple cisacting DNA sequences with families of cell-specific transcription factors that potentiate, or in some instances, repress transcriptional initiation (Zaret, 1996) . In embryonic development, expression of these cell-specific transcription factors is orchestrated through inductive signaling via growth factors and changes in interactions between cell surface proteins that occur during cell migration (Wall and Hogan, 1994; Yamaguchi and Rossant, 1995; Hogan, 1996; Zaret, 1996) . Analysis of transcription factor molecular structures, embryonic expression patterns and identification of target genes has facilitated elucidation of regulatory pathways involved in establishing cell-specific gene transcription.
The hepatocyte nuclear factor-3 (HNF-3a, b and g) pro-teins (Lai et al., 1991) and the Drosophila homeotic fork head (fkh) (Weigel and Jackle, 1990) protein were the first identified members of an extensive family of transcription factors which share homology in the winged helix DNA binding domain (for review see Kaufmann and Knochel, 1996) . Accumulating evidence demonstrates that the winged helix transcription factors are involved in embryonic pattern formation. The HNF-3a and HNF-3b genes are expressed during the gastrulation stage of embryogenesis (Ang et al., 1993; Monaghan et al., 1993; Sasaki and Hogan, 1993) . Targeted disruption of the murine HNF-3b gene results in mouse embryos that die in utero and exhibit defects in the organization of notochord, neurotube, somites and gut endoderm (Ang and Rossant, 1994; Weinstein et al., 1994) . Targeted disruption of the winged helix family members brain factor-1 (BF-1) and BF-2 genes in mice demonstrates their involvement in morphogenesis of the cerebral hemispheres and in branching of the ureter and renal collecting system, respectively (Xuan et al., 1995; Hatini et al., 1996) . Furthermore, targeted ablation of the winged helix (whn) gene results in the phenotypic abnormalities observed with the nude mouse mutation (Nehls et al., 1996) . Taken together, these embryonic studies indicate that the winged helix transcription factors play an integral regulatory role in cellular commitment events. We previously reported on the isolation of HNF-3/fork head homolog-8 (HFH-8) cDNA from a mouse lung cDNA library by low stringency hybridization with the HFH-1 cDNA probe and showed that abundant HFH-8 expression is restricted to the alveolar sac of the adult lung (Clevidence et al., 1994) . In our current study we determined that the embryonic expression pattern of HFH-8 is restricted to the extraembryonic and lateral mesoderm and their derivatives in the mouse embryo. We show that HFH-8 is expressed in the splanchnic mesenchyme throughout development, suggesting a role in lung and intestinal morphogenesis. Consistent with this embryonic expression pattern, we show that HFH-8 expression continues in endothelial cells of pulmonary capillaries and in connective fibroblasts of the adult alveolar sac and that several endothelial cell lines exhibit HFH-8 expression. Furthermore, HFH-8 transcripts are found in the connective tissue of the lamina propria and smooth muscle of the adult intestine. Finally, we develop an HFH-8 DNA binding consensus sequence and use this consensus to identify putative HFH-8 target genes expressed in mesenchymal cells of the developing lung.
Results

HFH-8 is expressed in the lateral and yolk sac mesoderm of 7-8 day p.c. mouse embryos
In order to determine embryonic expression patterns of the HFH-8 gene, we performed in situ hybridization of mouse embryo paraffin sections with a 33 P-labeled antisense HFH-8 RNA probe (Fig. 1) . After hybridization, stringent washes and autoradiography, dark field microscopy was used to visualize HFH-8 expressing cells in the tissues. In 7 day post coitum (p.c.) mouse embryos, expression of HFH-8 begins in the lateral mesoderm of the embryo proper and extraembryonic mesoderm (Fig. 1A,B ). In these primitive streak embryos, the HFH-8 expression pattern overlaps with that of the vascular endothelial growth factor receptor-2 (VEGF-R2) or Flk-1 gene (Fig. 1C,D) , a gene required for formation of the primitive endothelium (or angioblasts) and the hemangioblast in the mouse embryo (Shalaby et al., 1995) . No hybridization signals were observed with the HFH-8 sense RNA probe (data not shown).
In 8 day p.c. mouse embryos HFH-8 expression continues in the lateral mesoderm-derived somatopleuric and splanchnopleuric mesoderm (Fig. 1E,F) , which are situated adjacent to the dorsal aorta and form a continuum with the amnion and yolk sac mesoderm, respectively. HFH-8 expression persists in the extraembryonic mesodermal layers of both the amnion and the visceral yolk sac of 8 day p.c. mouse embryos (Fig. 1E,F) . These membranes enclose the entire mouse embryo at this stage of development except at the umbilical region containing the allantois, which expresses the HFH-8 gene (data not shown). HFH-8 and Flk-1 exhibit overlapping expression patterns in the somatopleuric and splanchnopleuric mesoderm and in the extraembryonic mesoderm of the yolk sac and allantois (Fig. 1G ,H and data not shown). However, HFH-8 is not expressed in head or cardiac mesenchyme, which exhibit abundant Flk-1 transcripts (Fig. 1G,H) . In more posterior embryo sections, HFH-8 is expressed in the splanchnic mesoderm that is juxtaposed to the foregut endoderm (Fig. 1I,J) .
During organogenesis HFH-8 expression is restricted to the splanchnic mesoderm
In situ hybridization of transverse sections of 9.5 day p.c. mouse embryos demonstrates that HFH-8 expression is restricted to the splanchnic mesoderm adjacent to the foregut and midgut endoderm, which lies between the gut endoderm and peritoneal cavity ( Fig. 2A,B) . HFH-8 expression is not observed in the foregut and midgut endoderm that lines the lumen of the embryonic gut ( Fig. 2A,B) . We identified the foregut endoderm by hybridization of an adjacent embryo section with the HNF-3b (Fig. 2C,D) antisense probe (Ang et al., 1993; Monaghan et al., 1993; Sasaki and Hogan, 1993) . Higher magnification of a transverse section through the lung bud demonstrates that HFH-8 is abundantly expressed in the splanchnic mesoderm contacting the lung primordium, which at this stage of mouse embryogenesis exists as an outpouch of foregut endoderm (Fig. 2E,F) . HFH-8 was also expressed in the mesenchyme that abuts the dorsal aorta, but at this stage does not completely surround this artery (Fig. 2E,F) . More posterior transverse sections demonstrate that HFH-8 is expressed Fig. 1 . HFH-8 is expressed in the lateral and extraembryonic mesoderm of primitive streak stage mouse embryos. In situ hybridization of transverse sections of paraffin embedded 7 day (A-D) or 8 day (E-J) mouse embryos with 33 P-labeled antisense HFH-8 RNA probe (A,B,E,F,I,J). After hybridization, stringent washes and autoradiography, dark field microscopy (right panels) was used to visualize HFH-8 expressing cells in the tissues. (A,B) HFH-8 is expressed in the lateral mesoderm and extraembryonic mesoderm of the 7 day post coitum (p.c.) mouse embryo. Flk-1 or the VEGF-receptor 2 is used as a marker gene for lateral and extraembryonic mesoderm and their derivatives (C,D,G,H) . (E,F) HFH-8 is expressed in derivatives of the lateral and extraembryonic mesoderm of 8 day p.c. mouse embryos. HFH-8 expression is observed in splanchnopleure and somatopleure mesoderm near the dorsal aorta and in yolk sac mesoderm and amnion. (H,I) HFH-8 expression is found in the splanchnic mesoderm adjacent to the foregut endoderm of 8.5 day p.c. mouse embryo. a, amnion; AC, amniotic cavity; DA, dorsal aorta; ect, ectoderm; EC, ectoplacental cavity; emb., embryo proper; en, endoderm; Extra Emb., extraembryonic; EM, extraembryonic mesoderm; Fg, foregut; He, heart; LM, lateral mesoderm; NT, neurotube; PC, peritoneal cavity; SV, sinus venosus; Sp, splanchnopleure; SM, splanchnic mesoderm; So, somatopleure; YSM, yolk sac mesoderm. Magnifications are ×8 (A-G) and ×30 (I,J).
in the splanchnic mesoderm (Fig. 2G,H ) that lines the entire midgut endoderm region as identified by the HNF-3b marker gene (Fig. 2I,J) . This expression pattern suggests a role for HFH-8 in the epithelial-mesenchyme induction of lung and gut morphogenesis.
At day 9.5 of gestation HFH-8 (Fig. 3A,B ) and flk-1 (Fig .   Fig. 2 . HFH-8 is expressed in the splanchnic mesoderm suggesting that it plays a role in lung and gut morphogenesis. In situ hybridization of transverse sections of paraffin embedded 9.5 day p.c. mouse embryos with 33 P-labeled antisense HFH-8 (A,B,E-G) RNA probe. (A,B) HFH-8 expression is found in the splanchnic mesoderm adjacent to the midgut and foregut endoderm. The HNF-3b cDNA probe is used as a marker gene for the adjacent foregut (C,D) and midgut (I,J) endoderm and for the neuroepithelium of the floorplate. (E,F) Higher magnification showing that HFH-8 is expressed in the splanchnic mesoderm juxtaposed to the lung bud derived from foregut endoderm. (G,H) HFH-8 is expressed in the splanchnic mesoderm adjacent to midgut endoderm. Fp, floorplate; LB, lung bud; Mg, midgut (see Fig. 1 for other abbreviations). Magnifications are 8× (A-D,G-J) and 30× (E,F). 3C,D) exhibit similar expression patterns in the yolk sac mesoderm of the blood islands and mesodermal layer of the amnion, but not in the embryo proper. Closer examination of the blood islands of the visceral yolk sac also shows that HFH-8 expression is restricted to the mesodermal cells (Fig. 3E,F) which constitute the primitive endothelium that expresses flk-1 mRNA (Fig. 3G,H) . HFH-8 is more uniformly expressed in the yolk sac mesoderm of the embryo proper side of the blood island vessel (Fig.  3E,F) . Flk-1 transcripts are observed in the mesodermal cells throughout the blood island vessel but its expression is absent in a subset of vessels which have not completed vasculogenesis and/or angiogenesis. HFH-8 and flk-1 thus exhibit partially overlapping expression patterns in the yolk sac mesodermal cells which constitute the primitive endothelial cells.
HFH-8 is expressed in the mesenchyme of embryonic respiratory and digestive systems
At 13.5 days of gestation HFH-8 expression continues in tissues derived from the lateral mesoderm. HFH-8 tran- scripts are observed in the mesenchyme of the oral cavity including the incisors, tongue, oropharynx, epiglottis, esophagus and trachea and in the mesenchyme of the lung, stomach and intestine (Fig. 4A,B) . By this stage of embry- (A,B) HFH-8 expression continues in the mesenchyme of the lung, stomach and intestine. Higher magnification of the embryonic lung (C,D) and stomach (G,H) demonstrating continued HFH-8 expression in the mesenchymal cells. Platelet-derived growth factor-a (PDGF) receptor was used as a marker gene for mesenchymal cells (Boström et al., 1996) in the embryonic lung (E,F) and stomach (I,J). Abbreviations are indicated in previous legends except for CC, costal cartilage; K, kidney. Magnifications are 5× (A,B) and 200× (C-J).
ogenesis, HFH-8 expression is also observed in the mesenchymal cells of the dorsal aorta and intersomitic arteries but it is not expressed in either the heart or other vasculature of the head, liver or kidney (Fig. 4A ,B and data not shown). No HFH-8 hybridization signals were observed in more lateral sections, which is consistent with HFH-8 expression in the intersomitic arteries and not in the sclerotome (data not shown). Higher magnification of embryonic lung shows that HFH-8 expression is restricted to its mesenchyme and exhibits higher expression levels in the mesenchymal cells adjacent to respiratory bronchioles (Fig. 4C,D) . Consistent with early HFH-8 expression in the splanchnic mesoderm adjacent to the gut diverticulum, HFH-8 transcription is restricted to the mesenchymal cells of the stomach, small intestine and colon (Fig. 4E ,F and data not shown). However, no HFH-8 hybridization signals are found in the endoderm-derived bronchiolar and stomach epithelial cells as identified by hybridization of adjacent mouse embryo sections with the HNF-3a antisense probe ( Fig. 4G,H) .
In 16 day p.c. mouse embryos, abundant HFH-8 expression continues in the mesenchyme of the mouth, incisors, lung, stomach and gut regions (Fig. 5A ,B and data not shown). Higher magnification of embryonic lung demonstrates that HFH-8 expression continues in the mesenchyme adjacent to respiratory bronchioles (Fig. 5C,D) . We identified the lung mesenchyme by hybridization of an adjacent embryo section with the platelet-derived growth factor-a (PDGFa) receptor (Fig. 5E ,F) antisense probe (Boström et al., 1996) . Abundant HFH-8 expression also continues in the mesenchyme and smooth muscle regions of the stomach and intestine (Fig. 5G ,H) which express the mesenchymal growth factor receptor for PDGFa (Fig. 5I,J) . These results indicate that HFH-8 is expressed in the mesenchyme of the developing mouse lung and intestine.
HFH-8 is expressed in the mesenchymal cells of the adult alveolar sac and intestine
Northern blot analysis demonstrates continued HFH-8 expression in the adult lung, moderate levels in the intestine and colon and lower expression levels in the prostate and placenta (Fig. 6 ). Our embryonic expression studies revealed that HFH-8 expression is restricted to the mesenchyme of the lung which is fated to become endothelium and connective fibroblasts of the adult alveolar sac. Consistent with these in situ hybridization results, Northern blot analysis ( Fig. 6 ) demonstrates that HFH-8 is abundantly expressed in two adult endothelial cell lines, namely human pulmonary artery endothelial cells (HPAEC) and human microvessel endothelial cells (HMEC). Consistent with pulmonary endothelial cell expression, in situ hybridization of adult lung sections demonstrates that HFH-8 (Fig. 7A ,B) exhibits a more broad expression pattern in the alveolar sac than that of the type II pneumocyte-specific surfactant protein-C (SP-C) gene (Fig. 7C,D ). Higher magnification of the adult alveolar sac indicates that HFH-8 is expressed in the endothelial cells of pulmonary capillaries as well as in the less abundant connective fibroblasts of the alveolar sac (Fig. 7E, F) . No HFH-8 hybridization signal was found in the bronchiolar epithelium (Fig. 7F ). These results demonstrate that HFH-8 is expressed in the endothelial and mesenchymal stromal cells of the adult alveolar sac.
Consistent with HFH-8 expression in the mesenchyme of the embryonic intestine, its adult expression is restricted to the fibroblasts and smooth muscle cells of the lamina propria that lies underneath the intestinal epithelium of the villus (Fig. 7G,H and data not shown). No HFH-8 hybridization is observed in the intestinal epithelium of the villus or the crypts of Lieberkühn. HFH-8 is also abundantly expressed in the smooth muscle layer within the muscularis externa region located on the exterior of the adult intestine (Fig. 7G,H) .
Determination of HFH-8 DNA binding sequence and transcriptional activation domain
In order to identify putative target genes expressed in mesenchymal cells, we determined the HFH-8 DNA binding consensus sequence using repetitive protein selection and PCR amplification as described previously . The HFH-8 protein-selected sites were cloned, radioactively-labeled and tested for HFH-8 protein-DNA complex formation by electrophoretic mobility shift assays (EMSA). Those sites that exhibited high binding affinity for the HFH-8 protein were chosen for DNA sequence determination and used to compile the HFH-8 DNA binding consensus sequence (Table 1) . The HFH-8 consensus binding sequence is VNDTRTTTRTDYR (where V is not T, D is not C, R is A or G and Y is C or T). In order to distinguish Fig. 6 . HFH-8 is expressed in adult lung, intestine and endothelial cell lines. Northern blots containing 2 mg of poly A + RNA isolated from the indicated human tissues or endothelial cell lines were probed with the HFH-8 or rat glyceraldehyde-3-phosphate dehydrogenase cDNA (GAPDH). Northern blot analysis demonstrates that HFH-8 is abundantly expressed in the adult lung and two different endothelial cell lines, namely human pulmonary artery endothelial cells (HPAEC) and human microvessel endothelial cells (HMEC). Moderate HFH-8 expression levels are also observed in small intestine, colon, prostate and placenta. Note that the weak hybridization signals in heart and smooth muscle (lower molecular weight) may be due to cross-hybridization with the Freac-2 message which possesses amino acid identity in the winged helix DNA binding domain (Hellqvist et al., 1996) . Fig. 7 . HFH-8 is expressed in mesenchyme-derived cells of the adult intestine and lung. HFH-8 in situ hybridization studies with paraffin embedded sections of adult mouse lung and intestine. Hybridization signals are illuminated with dark field micrographs (right panels). In situ hybridization studies with adult mouse lung demonstrate that HFH-8 (A,B) is more widely expressed in the alveolar sac than that of the type II pneumocyte-specific gene surfactant protein-C (C,D). Note that HFH-8 is also expressed in the endothelial cells lining the pulmonary arteriole. (E,F) Enlargement of the alveolar sac of the adult rat lung demonstrates HFH-8 expression in the endothelium of pulmonary capillaries, which are an abundant cell-type in the alveolar sac and in the less frequently occurring fibroblast cells. No hybridization is observed in the bronchiolar epithelium. (G,H) HFH-8 in situ hybridization studies with adult mouse intestine show HFH-8 expression in the connective tissue of the lamina propria of the villus and in the smooth muscle of the muscularis externa. No HFH-8 hybridization is found in the epithelium lining the intestinal villus or crypts of Lieberkühn. Abbreviations are indicated in previous legends except for al, alveolar sac; ar, arteriole; c, capillary; cr, crypts of Lieberkühn; LP, lamina propria; ME, muscularis externa; V, villus. Magnifications are 200× (A-D), 600× (E,F) and 50× (G,H). differences in HFH-8 binding affinities for these DNA sequences, we used low concentrations of recombinant HFH-8 protein (20 ng) for EMSA with the various DNA sequences listed in Table 2 (Fig. 8A ). These studies determined that sequences which adhered to the HFH-8 consensus sequence and possessed the TGTTTAT, TATTTAT or TGTTTGT core sequences possessed high binding affinity for the HFH-8 protein (Fig. 8A , lanes 1-6 and 9-12 and Table 2 , sequences 1-5). However, the HFH-8 protein was poorly bound by sequences with the TATTTGT core sequence (Fig. 8A , lanes 7 and 8 and Table 2 , sequence 6). Sequences that deviated from the HFH-8 consensus sequence in two positions or possessed a C residue in position 10 exhibited reduced affinity for HFH-8 (Fig. 8A , lanes 13-18 and Table 2 , sequences 7-18). These binding studies suggest that the DNA recognition properties of the HFH-8 protein differ from those of other characterized winged helix transcription factors .
The HFH-8 protein contains regions homologous to other winged helix proteins that are putative transcriptional activation motifs (Fig. 8B , regions II and III; Pani et al., 1992; Clevidence et al., 1994) . To determine which regions contribute to transcriptional activation, cotransfection assays (Pani et al., 1992; were employed with a reporter gene driven by multiple copies of a high affinity HFH-8 binding site to compare transcriptional activation of the wild-type HFH-8 protein with truncated HFH-8 proteins (see Section 4). To avoid complications with endogenous HFH-8 protein, we chose the human hepatoma HepG2 cell line that does not express HFH-8 to perform the cotransfection assays and monitored HFH-8 protein expression via EMSA with nuclear extracts (data not shown). None of the deletion constructs disrupted the winged helix DNA binding domain, which is sufficient to direct its nuclear localization . Cotransfection assays with the full-length HFH-8 cDNA expression plasmid provided an approximately 20-fold increase in reporter gene transcription compared to the CMV control plasmid. This activation was dependent on retention of the HFH-8 recognition sequence in the reporter construct (data not shown). Removal of the C-terminal 129 amino acids, including conserved region II and III sequences, and the first 36 N-terminal amino acids did not cause a significant decrease in transcriptional activity (Fig. 8B) . However, G  23  23  20  -85  ---19  -23  2  46  A  27  33  27  -15  ---81  -42  10  38  T  12  27  42  100  -100  100  100  -88  33  58  8  C  3 8  1 7  8  ------1 2  2  2 9  8  Consensus  C  A  T  T  G  T  T  T  A  T  A  T  G   A  T  g  a  g  T  c  A  g  G  a  g  C  Position  1  2  3  4  5  6  7  8  9  10  11  12  13 The HFH-8 DNA binding consensus sequence is compiled from 48 high affinity binding sites isolated by in vitro binding site selection using recombinant HFH-8 protein as described previously . Shown is the percent nucleotide occurrence for each nucleotide position in the HFH-8 binding site. Uppercase letters indicate nucleotides that are highly represented in DNA sites and lowercase letters indicate nucleotides that are represented less frequently. The HFH-8 DNA binding-core sequence is indicated by the underlined nucleotides. Table 2 HFH-8 binding activity The name of the winged helix DNA binding site deletion of the HFH-8 sequences between amino acid 180 and 247 caused a dramatic reduction in reporter gene expression, suggesting that these sequences are required for transcriptional activation (Fig. 8B ).
Identification of putative HFH-8 target genes in mesenchymal cells of lung and intestine
In order to identify putative HFH-8 target genes in lateral mesoderm-derived tissue, 38 potential regulatory regions of genes expressed in mesodermal cells of lung and intestine were searched with the HFH-8 DNA binding consensus sequence and 12 putative target genes were identified. Potential HFH-8 binding sites were found in the human Pselectin, E-selectin, the cytokines interleukin-8 (IL-8) and IL-6 and inducible nitric oxide (NO) synthase, collagenase, type IV collagenase and stromelysin genes ( Table 3 ). The mesenchymal growth factor receptor genes for the PDGFa and PDGFb receptors (Boström et al., 1996) , the Tie-1 receptor tyrosine kinase and the TGFb family member bone morphogenetic protein 4 (Bmp4; Hogan, 1996; Tonegawa et al., 1997) were also identified as potential HFH-8 target genes (Table 3) . We then synthesized oligonucleotides corresponding to six putative HFH-8 binding sites from these genes and used them for EMSA with recombinant HFH-8 protein (Fig. 9) . Abundant HFH-8 protein-DNA complex formation was observed with HFH-8 binding sites derived from promoter regions of the P-selectin, IL-8, NO synthase, collagenase and stromelysin (Fig. 9) . The E-selectin promoter also bound to recombinant HFH-8 protein but it did so with reduced affinity.
Cytokines stimulate the cell-specific expression of the Pselectin gene, whose expression mediates cell adhesion of leukocytes to the endothelium and their subsequent extravasation to the underlying injured tissue (Whelan, 1996) . Our binding studies suggest that HFH-8, which is constitutively expressed in endothelial cells, may participate in cytokine-mediated activation of P-selectin expression. In order to test this hypothesis, we performed HFH-8 cotransfection experiments in HepG2 cells (Fig. 10) , which are capable of responding to cytokines (IL-6; Samadani et al., 1995) , but lack the HFH-8 transcription factor. For these transfection studies, we used two P-selectin promoter luciferase gene reporter constructs, which either possessed (−459) or lacked (−309) the HFH-8 binding sequence. Neither IL-6 treatment nor HFH-8 cotransfection alone elicited significant stimulation of P-selectin promoter expression in HepG2 cells. However, combining IL-6 stimulation with HFH-8 cotransfection elicited substantial activation of the −459 P-selectin promoter expression (Fig. 10 ). In contrast, this stimulation was not observed with the −309 Pselectin promoter construct that lacked the HFH-8 binding site. These transfection studies suggest that the HFH-8 protein is necessary for endothelial-specific activation of Pselectin in response to cytokines. Table 2 . Inclusion of a 100-fold molar excess of homologous unlabeled oligonucleotide was used for competition ( + lanes). (B) Identification of HFH-8 transcriptional activation protein motifs. Schematic drawing of the HFH-8 protein indicating the position of the winged helix DNA binding domain (amino acids 45-145), the HFH-8 transcriptional activation motif identified in this study (striped box; amino acids 180-247) and sequences exhibiting homology with the region II (amino acids 338-351) and III (amino acids 361-372) activation motifs (Pani et al., 1992) . Also shown is the amino acid sequence of the HFH-8 activation domain where bold letters highlight residues possessing homology with several other transcription factors. The bar graph summarizes the transcriptional activity of the HFH-8 protein deletions assayed in HepG2 cell cotransfection assays with the TATA box driven CAT reporter gene construct containing four copies of the HFH-1 #25 binding site. Data is presented as fold activation of reporter gene expression by CMV-HFH-8 cotransfection compared to the empty CMV expression vector. Error bars represent standard deviation from three separate experiments. Approximately equal amounts of HFH-8 protein are expressed in each transfection as evidenced by EMSA (data not shown).
Discussion
HFH-8 expression in lateral and extraembryonic mesoderm and their derivatives
The winged helix proteins are a large family of transcription factors that share homology in the winged helix DNA binding domain and are involved in the differentiation of diverse cellular lineages (for review see Kaufmann and Knochel, 1996) . In this study we used in situ hybridization to determine the embryonic expression pattern of HFH-8 in stage-specific mouse embryos. We show that HFH-8 expression begins during the primitive streak stage of mouse embryogenesis in both lateral and yolk sac mesoderm. HFH-8 and flk-1 expression patterns exhibit similar expression patterns in the yolk sac mesoderm of the blood islands, which differentiate to form the primitive endothelial cells lining the vessels of the blood islands (Shalaby et al., 1995; Risau, 1997) and the allantois, which contributes to the vascular network of the placenta. HFH-8 and Flk-1 are coexpressed in the lateral mesoderm, which by day 8 of gestation form the somatopleuric and splanchnopleuric mesoderm and they continue to express both genes. Unlike Flk-1 (Shalaby et al., 1995; Risau, 1997) , HFH-8 is not expressed in the mesenchyme of the brain, liver, heart or kidney and therefore does not contribute to the vasculature in these organs. Embryo transplantation experiments between chicken and quail demonstrated that the somatopleuric and splanchnopleuric mesoderm contribute to the formation of the primitive endothelium in the embryo proper (Pardanaud et al., 1996) . HFH-8 expression continues in the splanchnic mesenchyme of the oral cavity, esophagus, trachea, lung, stomach, intestine and dorsal aorta, which differentiates to the endothelium and connective tissues of these organs. The restricted mesenchymal expression pattern of HFH-8 suggests that it is involved in the morphogenesis of specialized endothelium and connective tissue of respiratory and digestive systems.
Does HFH-8 play a role in mesenchyme induction of lung and gut morphogenesis?
During organogenesis HFH-8 expression is restricted to the splanchnic mesoderm contacting the embryonic gut, suggesting that it may participate in the mesenchymalepithelial induction of lung and gut morphogenesis (Bitgood and McMahon, 1995) . Lung morphogenesis involves the complex migration of epithelial cells into the surrounding mesenchyme, resulting in formation of the respiratory bronchioles and the alveolar sac-endothelial capillary bed (Minoo and King, 1994) . Development of the mouse gut involves the migration of both epithelial and mesenchymal cells, resulting in formation of the adult intestinal villus and crypt structure (Potten and Loeffler, 1990) . These developmental events require mesenchymal-epithelial cell interactions which include autocrine growth factor stimulation and cell-cell or cell-matrix contacts that induce cellular proliferation, migration and differentiation (Potten and Loeffler, 1990; Minoo and King, 1994) . The lung and gut mesenchyme expresses growth factor receptors which respond to protein ligands secreted by the adjacent epithelial cells. Disruption of precise levels of these growth factors leads to 
VNDTRTTTRTDYR
Abbreviations for genes expressed in fibroblasts and/or endothelial cells are the following: PDGF, platelet-derived growth factor receptors; IL-6, interleukin-6; NO synthase, inducible nitric oxide synthase; Tie-1, receptor tyrosine kinase; Bmp-4, bone morphogenetic protein-4. Other abbreviations are H, human; M, mouse; R, rat. Lowercase letters represent nucleotides which deviate from the HFH-8 consensus sequence. The name of the putative HFH-8 target gene, GenBank accession number (GenBank no.), position in the gene and the HFH-8 binding sequence are shown.
HFH-8 protein binding affinity (HFH-8 BA) was determined in EMSA with recombinant HFH-8 protein (Fig. 9 ) and summarized as the following: ++++, strong; +++, high; ++, moderate; +, weak; ND, determination not done. a Nucleotide abbreviations in the HFH-8 DNA binding consensus sequence are as follows: V is not T, N is any nucleotide, D is not C, R is A or G and Y is C or T.
profound defects in lung morphogenesis. Misexpression of signaling proteins including keratinocyte growth factor (Simonet et al., 1995) , bone morphogenetic protein 4 (Bmp4; Bellusci et al., 1996) , transforming growth factorb1 (Zhou et al., 1996) or sonic hedgehog (Bellusci et al., 1997) resulted in defects in branching morphogenesis. Continued expression of HFH-8 in the splanchnic mesoderm during lung and gut morphogenesis suggests that HFH-8 may regulate mesenchymal genes involved in this developmental processes.
Our expression studies identify HFH-8 as the sixth member of the winged helix transcription factor family which is restricted to the mesenchymal cells of the mouse embryo. These include fkh6, mesenchyme fork head1 (MFH1), the mesoderm/mesenchyme fork head 1(MF1), MF2 and MF3 genes (Miura et al., 1993; Sasaki and Hogan, 1993; Kaestner et al., 1996) . Of these winged helix transcription factors, the expression patterns of fkh-6 more closely resemble that of HFH-8 in the embryonic lung, tongue, incisors, stomach and intestine (Kaestner et al., 1996) . In the developing intestine and stomach, fkh-6 is expressed in a thin mesenchymal cell layer adjacent to the gut endoderm and thus exhibits a more restricted expression pattern in the gut mesenchyme than that of HFH-8. Targeted disruption of the fkh6 gene in mice results in structural abnormalities in the villus-crypt structures of the stomach and intestine due to an increase in the number of proliferating intestinal epithelial cells (Kaestner et al., 1997) . Furthermore, this aberrant proliferation may be caused by decreased expression of Bmp2 and Bmp4 in the intestinal mesenchyme of mice that are homozygous null for the fkh6 gene. Interestingly, we identified a putative HFH-8 binding site in the Bmp4 gene (Table 3) suggesting that HFH-8 may participate in regulating Bmp4 expression in lateral mesoderm-derived tissue (Hogan, 1996; Tonegawa et al., 1997) . Future genetic analysis using mice containing targeted Hfh8 gene disruption may determine whether it also regulates the expression of mesenchymal signaling molecules which are involved in epithelial proliferation and morphogenesis of the intestine.
HFH-8 is expressed in the endothelium and connective fibroblasts of the adult alveolar sac
Our current studies demonstrate that HFH-8 expression is restricted to the mesenchymal cells of the developing respiratory bronchioles (Figs. 2-5 ), which are fated to become endothelial cells of the pulmonary capillaries and fibroblasts of the alveolar sac. In support of this expression pattern, we detected abundant HFH-8 mRNA levels in several adult endothelial cell lines (HMEC and HPAEC). We previously suggested that HFH-8 expression is localized to the alveolar type II cells (Clevidence et al., 1994) , but HFH-8 is not expressed in primary cultures of alveolar type II cells (Ikeda et al., 1996) . We now show that HFH-8 expression pattern is more broadly distributed in the cells of the adult alveolar sac than that of the SP-C gene, which hybri- Fig. 9 . Identification of putative HFH-8 target genes in mesenchymal cells of lung and intestine. HFH-8 consensus sequence was used to search endothelial and fibroblast genes to identify putative HFH-8 binding sites in the genes encoding human P-selectin, E-selectin, stromelysin, interleukin-8 (IL-8), inducible nitric oxide synthase (NO synthase) and rat (R) collagenase. Double stranded oligonucleotides were synthesized to these putative HFH-8 binding sequences (Table 3 ) and used for EMSA with recombinant HFH-8 protein. Inclusion of a 100-fold molar excess of homologous unlabeled oligonucleotide was used for competition (+ lanes). Fig. 10 . HFH-8 is required for IL-6 activation of P-selectin promoter expression in HepG2 cells. P-Selectin promoter luciferase constructs that either contained (−459) or lacked (−309) the HFH-8 binding site were cotransfected into HepG2 cells with CMV-HFH-8 expression vector. The CMV expression vector lacking the HFH-8 cDNA was used as a control (CMV). Thirty-six hours after transfection, HepG2 cells were stimulated for 12 hours with IL-6 (400 units/ml) or not treated (−IL-6) and then protein extracts were isolated and analyzed for luciferase enzyme activity. Data is presented as fold activation of P-selectin promoter expression by CMV-HFH-8 cotransfection compared to the empty CMV expression vector with or without IL-6 stimulation. Error bars represent standard deviation from three separate transfections performed in the same experiment.
dizes to very few cells per alveolar sac (Fig. 7) . These results are consistent with HFH-8 expression in the widely distributed endothelial cells lining the pulmonary capillaries and in the connective fibroblast cells of the alveolar sac (Fig. 7) . Branching morphogenesis of the lung allows the precise alignment of the mesenchyme-derived endothelial cells with the endoderm-derived alveolar type I epithelium for proper air exchange with the blood. The observation that HFH-8 expression is restricted to the developing mesenchyme adjacent to the respiratory bronchioles suggests its involvement in the formation of this specialized endothelial-epithelial cellular architecture.
Identification of putative target genes in mesenchymal cells of the lung and intestine
The use of the HFH-8 consensus binding sequence to search promoter regions allowed us to identify potential HFH-8 target genes in the mesenchyme of lung and/or intestine. We have shown that recombinant HFH-8 protein binds to potential regulatory regions of several genes involved in injury and repair of endothelial cells. These putative HFH-8 target genes include the stromelysin and collagenase genes which are induced during endothelial cell injury and are involved in extracellular matrix restructuring during angiogenesis (Cornelius et al., 1995) . Partially overlapping expression patterns are exhibited by the HFH-8 and Tie-1 receptor tyrosine kinase genes . Mice that are homozygous null for the Tie-1 gene exhibit defects in establishing tight junctions between endothelial cells in developing blood vessels (Sato et al., 1995) . Interestingly, a putative HFH-8 binding site was found in both mouse and human Tie-1 promoter regions which were sufficient to direct reporter gene expression to the primitive endothelial cells (Korhonen et al., 1995) . HFH-8 may also participate in the activation of the IL-6 and IL-8 cytokines in endothelial and fibroblast cells and may mediate blood pressure homeostasis through regulation of nitric oxide synthase expression in pulmonary endothelial cells (Forstermann et al., 1994) . Putative HFH-8 binding sites were present in the PDGF receptors, which are required for lung mesenchyme proliferation, and disruption of this signaling pathway leads to defects in the formation of alveolar structures (Boström et al., 1996) . Thus, HFH-8 potentially regulates genes critical for inflammation and tissue remodeling following injury, as well as mesenchyme proliferation and endothelial differentiation.
Recent studies have demonstrated that oncostatin M, which binds to the IL-6 receptor, stimulates expression of P-selectin in human endothelial cells (Yao et al., 1996) . Cytokine induction of P-selectin expression is critical for leukocyte adhesion to endothelial cells and their extravasation to the underlying injured tissue (Whelan, 1996) . Although HFH-8 is constitutively expressed in endothelial cells, our transfection studies suggest that HFH-8 protein is required for endothelial-specific IL-6-mediated induction of P-selectin expression (Fig. 10) . Interestingly, two potential binding sites for the signal transducer and activator of transcription-3 (STAT-3) are located adjacent to the HFH-8 recognition sequence in the P-selectin promoter. HFH-8 and the IL-6 responsive STAT3 factor may thus collaborate to mediate endothelial cell-specific activation of P-selectin gene expression in response to cytokines.
FREAC-2 shares sequence homology with the HFH-8 transcriptional activation domain
Cotransfection assays demonstrate that the HFH-8 protein is a potent transcriptional activator requiring amino acid residues 180-247 for activation, but the conserved region II and III sequences were dispensable for function. Although several winged helix proteins require these conserved sequences for transcriptional activation (Pani et al., 1992; Lim et al., 1997) , other family members do not contain these sequences and utilize other activation motifs (Li and Tucker, 1993; Bassel-Duby et al., 1994; Li et al., 1995; Overdier et al., 1997) . Interestingly, the HFH-8 transcriptional activation domain (Fig. 8B , HFH-8 amino acids 188-216) demonstrates homology with several transcription factors. These include the Drosophila broad complex protein isoform Z4 (GenBank Accession number U51585) and the HNF-1a (A39262) proteins. The HFH-8 transcriptional activation domain also exhibits homology with forkhead related activator-2 (Freac-2; U13220, amino acids 197-230), a related winged helix family member which is expressed in pulmonary epithelial cell lines and shares amino acid identity in the winged helix motif of the HFH-8/Freac-1 protein (Hellqvist et al., 1996) . These comparisons show that the Freac-2 protein may not only share homology with the HFH-8/Freac-1 winged helix domain (Hellqvist et al., 1996) , but also with the HFH-8 transcriptional activation motif.
In summary, we showed that HFH-8 expression initiates during gastrulation of the mouse embryo in the extraembryonic mesoderm and in the lateral mesoderm, the later of which gives rise to the somatopleuric and splanchnopleuric mesoderm. During organogenesis, HFH-8 expression is found in the splanchnic mesoderm in close apposition to the gut endoderm, suggesting a role in mesenchymal-epithelial induction of lung and gut morphogenesis. HFH-8 expression continues in splanchnic mesoderm-derived tissues of the adult, including the endothelium and connective fibroblasts of the alveolar sac, and in the lamina propria and smooth muscle of the intestine.
Experimental procedures
In situ hybridization of stage-specific mouse embryos and adult intestine and lung
In situ hybridization of paraffin embedded embryos was performed with 33 P-labeled antisense RNA probes generated from a NotI linearized mouse HFH-8 cDNA pGEM-1 (EcoRI; clone 15B) template using T-7 RNA polymerase and [ 33 P]UTP (Amersham) as described (Duncan et al., 1994) . The NotI site is situated 3′ to the winged helix DNA binding domain in the HFH-8 cDNA and the antisense RNA probe thus lacks winged helix coding sequences, eliminating the possibility of cross-hybridization. Antisense 33 P-labeled HFH-8 RNA probes were hybridized to sectioned dewaxed mouse embryos, adult lung or intestine and rinsed at high stringency followed by autoradiography as described (Duncan et al., 1994) . A dark field condenser was used to enhance the visualization of the silver grains corresponding to specific HFH-8 hybridization.
In vitro DNA binding site selection and electrophoretic mobility shift assays
HFH-8 winged helix DNA binding domain (amino acids 40-160) was fused to the GST protein and GST-HFH-8 fusion protein was isolated from bacterial cultures and purified to homogeneity via glutathione affinity chromatography . The affinity purified GST-HFH-8 fusion protein was used to isolate high affinity HFH-8 binding sites from a pool of partially degenerate oligonucleotides containing 14 degenerate positions by six cycles of repetitive protein selection and PCR amplification as described in Overdier et al. (1994) . The HFH-8 protein-selected sites were cloned in pGEM1 and the DNA insert was labeled during PCR amplification using 5′-labeled T7 and SP6 primers and tested for HFH-8 protein complex formation by electrophoretic mobility shift assays (EMSA) with 20 ng of affinity purified recombinant GST-HFH-8 protein using methods described previously . We chose 48 high affinity HFH-8 binding sites from a total of 110 selected DNA sites to determine the HFH-8 consensus sequence. The frequency of occurrence for each nucleotide was used to compile a 13 nucleotide HFH-8 binding consensus sequence (Table 1 ; the 14th nucleotide position was degenerate). We used the HFH-8 DNA binding consensus sequence to search 38 genes expressed in lung and/or intestinal mesenchymal cells (extracted from GenBank). Twelve of these promoters contained putative HFH-8 binding sites. Double stranded oligonucleotides were made to six potential HFH-8 binding sites in these promoter regions (see Table  3 ) or to previously described winged helix DNA binding sites which conformed to the HFH-8 consensus sequence (e.g. HFH-1 #25). Radioactivelylabeled oligonucleotides containing HFH-8 binding sites were used for EMSA with 20 ng of affinity purified GST-HFH-8 fusion protein and 4 mg of poly dIdC-dIdC in a 20 ml binding reaction as described previously .
Construction of HFH-8 cDNA deletions and cotransfection assays
In order to determine the HFH-8 transcriptional activity, cotransfection assays were performed in human hepatoma HepG2 cells, which do not express endogenous HFH-8 protein. These assays used a reporter plasmid containing four copies of the high affinity HFH-8 binding site (HFH-1 #25) upstream of a TATA box-driven chloramphenicol acetyltransferase (CAT) gene, an expression vector that used the CMV promoter to express the HFH-8 cDNA sequences and a CMV promoter driven b-galactosidase control plasmid to normalize for differences in transfection efficiency (Pani et al., 1992) . The full-length HFH-8 cDNA was cloned as an EcoRI-HindIII fragment (5′-3′) in the CMV expression vector (Pani et al., 1992) . HFH-8 cDNA deletions were created by a polymerase chain reaction (PCR)-mediated strategy using Vent DNA polymerase (New England Biolabs) as described previously (Pani et al., 1992) .
Human hepatoma HepG2 cells were maintained in monolayer cultures and transfected using Lipofectin reagent (GIBCO) according to the manufacturer's protocol (35 mm plates, 400 ng CMV-HFH-8 expression vector, 1600 ng of 4× HFH-8 #25 CAT reporter, 100 ng CMV-b-galactosidase construct and 10 ml lipofectin). Cellular protein extracts were prepared from transfected cells 48 h after transfection and analyzed for both CAT and b-galactosidase enzyme activity as described previously . To determine the expression of HFH-8 deletion mutants during cotransfection experiments, nuclear extracts were prepared from HepG2 cells transfected with the HFH-8 cDNA constructs and analyzed by EMSA as described previously (Pani et al., 1992) . PSelectin promoter luciferase constructs (1600 ng) were cotransfected with CMV-HFH-8 expression vector (400 ng) and 100 ng CMV-b-galactosidase construct into HepG2 cells using lipofectin reagent. Thirty-six hours following transfection, cells were treated for 12 h with 400 units/ml of IL-6 (Boehringer Mannheim) or not treated prior to analyzing cellular extracts for luciferase and bgalactosidase enzyme activity as described previously Ye et al., 1997) . The −459 P-selectin promoter contained the HFH-8 binding site, whereas this sequence was deleted in the −309 P-selectin promoter construct.
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